2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Hou, Y; Lv, M; Nie, Y; Wang, T; Zhao, G | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Adenocarcinoma
| Article | Year |
|---|---|
ERĪ²-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Base Sequence; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Male; Middle Aged; Midkine; Nerve Growth Factors; Nitriles; Phenols; Propionates; Protein Binding; Pyrazoles; Response Elements; RNA Interference; Signal Transduction; Statistics, Nonparametric; Transcription, Genetic | 2012 |